FDA Inspection 1191619 — ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. — FEI 2111358

The FDA completed an inspection of ANI Pharmaceuticals, Inc. on Nov 18, 2022 in Baudette, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 18, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Baudette, MN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.